• Media type: E-Article
  • Title: P300 cognitive assessment in patients with first-episode psychosis: a prospective case-control study
  • Contributor: Hassan, Wageeh A.; Darweesh, Alaa Eldin M.; Abdel-Rahman, Ahmed A.; Ahmad, Hossam Eddin Khalifa; Hassaan, Shehab H.; Noaman, Mostafa M.; Fahmy, Iman F. G.
  • Published: Springer Science and Business Media LLC, 2020
  • Published in: Middle East Current Psychiatry, 27 (2020) 1
  • Language: English
  • DOI: 10.1186/s43045-020-00031-2
  • ISSN: 2090-5416
  • Keywords: Psychiatry and Mental health
  • Origination:
  • Footnote:
  • Description: <jats:title>Abstract</jats:title><jats:sec> <jats:title>Background</jats:title> <jats:p>Several studies using event-related potential (ERP) methods have reported a relationship between the cognitive dysfunction of patients with psychosis and P300 latency and amplitude. P300 follow-up studies in patients with schizophrenia receiving antipsychotic treatment revealed that the P300 amplitudes were increased while other studies showed limited changes in the P300 amplitude even after antipsychotics use.</jats:p> </jats:sec><jats:sec> <jats:title>Results</jats:title> <jats:p>We found that at the first presentation, all patients’ groups have significantly lower amplitude and more prolonged latency of P300 than controls. All the first-episode psychosis patients showed a significant improvement of P300 amplitude mean scores after 1 year, but with no significant change in the P300 latency. There was an inverse correlation between the patients’ PANSS scores and their P300 latency and amplitude values.</jats:p> </jats:sec><jats:sec> <jats:title>Conclusion</jats:title> <jats:p>P300 amplitude and latency might be of clinical value in the evaluation of cognitive functions in the first-episode psychosis patients. The abnormalities in P300 may be improved with continuous control of psychotic symptoms with psychotropic medications.</jats:p> </jats:sec>
  • Access State: Open Access